Orexo AB
OTC:ORXOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orexo AB
OTC:ORXOF
|
SE |
|
A
|
Aboitiz Equity Ventures Inc
XPHS:AEV
|
PH |
|
Bayan Resources Tbk PT
IDX:BYAN
|
ID |
|
M
|
Minth Group Ltd
HKEX:425
|
TW |
|
PayPal Holdings Inc
MIL:1PYPL
|
US |
|
Noah Holdings Ltd
NYSE:NOAH
|
CN |
|
Country Condo's Ltd
NSE:COUNCODOS
|
IN |
|
C
|
CRH PLC
NYSE:CRH
|
IE |
|
T
|
Tx Group Ltd
SIX:TXGN
|
CH |
|
G
|
General Dynamics Corp
F:GDX
|
US |
|
Aviva PLC
LSE:AV
|
UK |
|
S
|
Shanghai Zijiang Enterprise Group Co Ltd
SSE:600210
|
CN |
|
Australian Goldfields Ltd
OTC:GRXXF
|
CA |
|
B
|
British American Tobacco plc
SWB:BMTA
|
UK |
|
H
|
Hapag-Lloyd AG
DUS:HLAG
|
DE |
|
C
|
Cloudflare Inc
XHAM:8CF
|
US |
|
N
|
NCC Group PLC
F:NZB
|
UK |
|
K
|
Kimberly-Clark Corp
XMUN:KMY
|
US |
|
Northern Star Resources Ltd
ASX:NST
|
AU |
Bankruptcy Probability
Orexo AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Orexo AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Orexo AB
STO:ORX
|
48.2m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
655.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
167.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
129B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
100.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Orexo AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Orexo AB has total debt of 2.8m SEK. This includes both short-term (0 SEK) and long-term (2.8m SEK) debt.
You can find a full breakdown on its Balance Sheet.
